COPD/Asthma adverse effects and clinical protocols Flashcards
What are the adverse effects for ICS inhalers
oral thrush (candidiasis), cough, dysphonia
what are the counseling points for ICS inhalers?
- rinse mouth and spit after each use to prevent thrush
- may increase pneumonia risk in pts with COPD
- titrate to lowest effective dose
- high doses increase the risk for systemic side effects
what is a counseling point for pulmicort respules?
use jet nebulizer and should not mix with other neb medications
what are the adverse effects for LABA inhalers?
tachycardia, headache, tremor, hypokalemia
what are the clinical pearls for LABAs?
- prolonged QT seen in intentional overdoses
- not for acute symptoms
- may be helpful to exercise for induce bronchospasm
- formoterol and indacaterol capsules shouldn’t be taken orally
what are the black box warnings for LABAs?
- for increased risk of asthma related death for all monotherapy LABA use should not be used alone for asthma management
- for increasing hospitalizations in pediatric and adolescent patients
what are the adverse effects for LAMAs?
dry mouth, dizziness, blurred vision, upper respiratory infections, and paradoxical bronchospasms
what is a clinical pearl for LAMA inhaler Spiriva?
has been approved for asthma > or equal to 12yo
what are some clincal pearls for ICS/LABA combo inhalers?
- guidelines recommend combo LABA/ICS in asthma, as LABA shouldn’t be used as monotherapy
- combo products developed to create convenient packaging and adherence
what is the clinical pearl for LABA/LAMA combo?
not indicated in use for asthma
what are the adverse effects for leukotriene modifiers?
neuropsych events (agitation, anxiety, hallucinations, depression), Churg-Strauss syndrome (rare), increased hepatic transaminases (zafirlukast/ zileuton)
what are the clinical pearls for leukotriene modifiers?
- less effective than low dose ICS and ICS/LABA in athma
- have not been adequately trailed in COPD
what are the specific clinical pearls for monteukast?
- minor substrate CYP2C8/9 and 3A4
- not for acute asthma relief
- boxed warning: neuropsych events
what are the specific clinical pearls for zafirlukast?
- take at least 1 hr b4 or 2 hrs after meals
- can increase INR
- major substrate: minor inhibitor of CYP2C9
what are the specific clinical pearls for zileuton?
- weak CYP1A2 inhibitor
- take with food
what are the adverse effects of theophylline?
insomnia, GI upset, hyperactivity, hypotension, tremor